P.A.W. Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
P.A.W. Capital's AMGN Position: Q3 2026 in Review
P.A.W. Capital reduced its Amgen (AMGN) stake by 19% in Q3 2026, selling an estimated $1.82M and leaving 19,235 shares worth $8.11M. The position accounts for 2.42% of the portfolio, ranked #15.
P.A.W. Capital first reported a position in AMGN in Q2 2015 and has held it in 17 quarters since. The position peaked at $8.62M in Q2 2026. 3,274 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- P.A.W. Capital held 19,235 shares of Amgen worth $8.11M as of Q3 2026.
- P.A.W. Capital sold 4,575 Amgen shares in Q3 2026, an estimated $1.82M.
- Amgen made up 2.42% of P.A.W. Capital's portfolio in Q3 2026, its #15 holding.
- P.A.W. Capital first reported a position in Amgen in Q2 2015 and has held it in 17 quarters since.
- P.A.W. Capital's Amgen position peaked at $8.62M in Q2 2026.
- 3,274 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on P.A.W. Capital's 13F filing for Q3 2026, filed 16 Nov 2026.